| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/14/2005 | CN1668212A Compositions comprising lactoferrin |
| 09/14/2005 | CN1666778A Anti-oxidation, anti-senium oyster product and its preparation method |
| 09/14/2005 | CN1218960C Ginkgo protein GAPIIa and its preparing method and use |
| 09/14/2005 | CN1218942C Antifibrosis pyridinone compound and its preparing process |
| 09/14/2005 | CN1218941C Process for preparing ethyl-sulfonylpiperidine derivatives |
| 09/14/2005 | CN1218940C Nitric oxide synthase inhibitors |
| 09/14/2005 | CN1218936C Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments |
| 09/14/2005 | CN1218736C Fragrance health-care product |
| 09/14/2005 | CN1218726C Heat-clearing and stagnation-dissipating particle medicine and preparation method thereof |
| 09/14/2005 | CN1218698C Pharmaceutical composition for treatment and prevention of liver fibrosis and cirrhosis |
| 09/14/2005 | CN1218696C Thermoformable solid pharmaceutical composition for controlled release of perindopril |
| 09/14/2005 | CN1218692C Film coating |
| 09/13/2005 | US6943251 Preparation of salts of 4-[4-[(1R)-[4-(trifluoromethyl)phenyl]-2-methoxyethyl]-(3S)-methyl-1-piperazinyl]-4-methyl-1-[(4,6-dimethyl-5-pyrimidinyl)carbonyl] |
| 09/13/2005 | US6943199 Eating disorders; psychological disorders; antidiabetic agents; cardiovascular disorders |
| 09/13/2005 | US6943195 Cycloalkenone derivative |
| 09/13/2005 | US6943188 For manufacture of medicament for use in treating asthma, multiple sclerosis, inflammatory disease |
| 09/13/2005 | US6943186 Administering benzopyrazolyl compound for therapy of sepsis |
| 09/13/2005 | US6943185 Use of 2-methyl-thiazolidine-2,4-dicarboxylic acid and/or physiologically compatible salts thereof for producing a medicament for treating cancers |
| 09/13/2005 | US6943184 For therapy of Alzheimer's disease, Parkinson's disease, Pick's disease, Korsakoff s disease cerebral ageing, of mood disorders, of pain and of tobacco withdrawal |
| 09/13/2005 | US6943183 Antiproliferative agnets; anticancer agents; skin disorders; restenosis |
| 09/13/2005 | US6943182 Cyclopentabenzofuran derivatives and their use |
| 09/13/2005 | US6943180 Substituted N-arylsulfonyl-proline derivatives as potent cell adhesion inhibitors |
| 09/13/2005 | US6943174 6,5-Fused bicyclic heterocycles |
| 09/13/2005 | US6943173 Treatment of a number of CNS and periphereal disorders, particularly stress, anxiety, depression, cardiovascular disorders, and eating disorders. |
| 09/13/2005 | US6943172 Antitumor agents; anticancer agents; sexual disorders; cardiovascular disorders |
| 09/13/2005 | US6943171 For therapy of urological, vascular or pulmonary disorders |
| 09/13/2005 | US6943163 7-Alkyl and cycloalkyl-substituted imidazotriazinones |
| 09/13/2005 | US6943160 Morpholine derivatives as antagonists of orexin receptors |
| 09/13/2005 | US6943156 3-(5,6,7,8-Tetrahydro-(1,8)naphthyridin-2-yl)-ethoxy)-11H-di-b enzo(1,4)oxazepin-10-yl)-acetic acid; inhibiting bone resorption; vascular restenosis; osteoporosis; angiogenesis inhibitors; diabetic retinopathy; anticarcinogenic agents |
| 09/13/2005 | US6943150 Antiapoptosis polypeptides or fusion proteins coded by nucleic acids |
| 09/13/2005 | US6943148 Methods for delivering therapeutics across blood-barrier and for altering receptor binding affinity |
| 09/13/2005 | US6943146 Control cell proliferation, cell differentiation; culture product |
| 09/13/2005 | US6943022 Inhibition of apoptosis by the expression of antisense RNA of caspase-3 |
| 09/13/2005 | US6943016 incubating a mixture of astrocytes and glial cells from patient surgical resection, culturing, astrocytes joining to the culture vessel, removing the un-attached cells; purification; treating CNS trauma, neurodegenerative disorders |
| 09/13/2005 | US6942966 Methods for processing chemical compounds having reactive functional groups |
| 09/13/2005 | US6942870 For prevention of photodamage skin, for topical application |
| 09/13/2005 | US6942853 Latent fusion protein |
| 09/13/2005 | US6942849 Incorporation of exogenous lactic bacteria into the oral microflora |
| 09/13/2005 | CA2469019C Pharmaceutical composition comprising a 5ht1 receptor agonist |
| 09/13/2005 | CA2371583C Piperazine derivatives useful as ccr5 antagonists |
| 09/13/2005 | CA2323863C Methods and compositions for treating and preventing mucositis |
| 09/13/2005 | CA2317462C 4-(2-keto-1-benzimidazolinyl)piperidine compounds as orl1-receptor agonists |
| 09/13/2005 | CA2314893C Opioid agonist/antagonist combinations |
| 09/13/2005 | CA2292927C New imidazolin compounds, the process for preparing them and the pharmaceutical compositions that contain them |
| 09/13/2005 | CA2279276C Arylsulfonylamino hydroxamic acid derivatives |
| 09/13/2005 | CA2231105C Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quinolinone derivatives |
| 09/09/2005 | WO2005083124A1 Antisense oligonucleotide modulation of stat3 expression |
| 09/09/2005 | WO2005083076A1 Immune stimulant oligonucleotide inducing interferon alpha |
| 09/09/2005 | WO2005083071A1 Polynucleotide participating in rheumatoid arthritis and utilization of the same |
| 09/09/2005 | WO2005082905A1 Bicyclic heterocyclic compound |
| 09/09/2005 | WO2005082904A1 Preventive and/or therapeutic agent for neutrophilic inflammation disease |
| 09/09/2005 | WO2005082887A1 Pyrimidine derivative |
| 09/09/2005 | WO2005082872A1 Benzothiazin-3-one compound and intermediate therefor |
| 09/09/2005 | WO2005082870A1 Abc transporter inhibitor |
| 09/09/2005 | WO2005082855A1 Novel pyridine derivative and pyrimidine derivative (2) |
| 09/09/2005 | WO2005082854A1 Novel pyridine derivative and pyrimidine derivative (1) |
| 09/09/2005 | WO2005082847A1 Bicyclo derivative |
| 09/09/2005 | WO2005082402A1 Preventive/therapeutic agent for organ fibrosis |
| 09/09/2005 | WO2005082394A1 Phosphorylation inhibitors for insulin receptor |
| 09/09/2005 | WO2005082391A1 AGONIST TO HUMAN β3 ADRENALINE RECEPTOR |
| 09/09/2005 | WO2005082351A1 Therapeutic agent for neurodegenerative disorder |
| 09/09/2005 | WO2005082135A1 Axon regenration promoter |
| 09/09/2005 | WO2005046611A3 Glucoimidazole and polyhydroxycyclohexenyl amine derivatives to treat gaucher disease |
| 09/09/2005 | WO2005014584A8 3-(indol-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones,3-(benzimidazol-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones, and 3-(indolin-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones; their preparation and use as modulators of apoptosis |
| 09/09/2005 | CA2560664A1 Benzothiazin-3-one compound and intermediate therefor |
| 09/09/2005 | CA2557541A1 Pyrimidine derivatives |
| 09/09/2005 | CA2557276A1 Preventive and/or therapeutic agent for neutrophilic inflammatory diseases |
| 09/09/2005 | CA2556759A1 Beta-lapachone and s-phase drug combinations for cancer treatment |
| 09/09/2005 | CA2555245A1 Antisense oligonucleotide modulation of stat3 expression |
| 09/09/2005 | CA2543861A1 Novel pyridine derivative and pyrimidine derivative (2) |
| 09/09/2005 | CA2543859A1 Novel pyridine derivative and pyrimidine derivative (1) |
| 09/08/2005 | US20050197497 Used to improve the therapeutic efficacy of current cancer treatment; sensitizing cancerous cells to treatment with conventional anti-tumor drugs |
| 09/08/2005 | US20050197392 O-desmethylvenlafaxine and methods of preparing and using the same |
| 09/08/2005 | US20050197380 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 09/08/2005 | US20050197372 Use of valsartan or its metabolite to inhibit platelet aggregation |
| 09/08/2005 | US20050197362 Preventives/remedies for urinary disturbance |
| 09/08/2005 | US20050197357 Anticholinergics which may be used as medicaments as well as processes for preparing them |
| 09/08/2005 | US20050197353 E.g., N-[(S)-2-diphenylamino-1-(5-oxo-4,5-dihydro[1,3,4]oxadizol-2-yl)ethyl]-2-(2-methylaminopyrimidin-4-yl)-1H-indole-5-carboxamide; used for treating rheumatoid arthritis, osteoarthritis, asthma, cardiac infarction, Alzheimer's diseases, cancer diseases, atherosclerosis, etc. |
| 09/08/2005 | US20050197351 Such as 4-{N-[4-(4-methylbenzenesulfonylamido)benzyl]acetamido}-3-phenyl-2-(piperidine-1-yl)-3,4-dihydroquinazoline; for therapy of angina pectoris, high blood pressure, myocardial disease, pain and epilepsy by blocking the T-type calcium channel |
| 09/08/2005 | US20050197350 Melanin Concentrating Hormone (MCH) receptor antagonist; clinical obesity; eating disorders; N-(cis-4-{[4-(dimethylamino)quinolin-2-yl]amino}cyclohexyl)-3-methoxy-benzamide; N-(2-chlorobenzyl)-N'-(cis-4-{[4- -(dimethylamino)-5,6,7,8-tetrahydroquinazolin-2-yl]amino}cyclohexyl)urea; pyrimidine analogs |
| 09/08/2005 | US20050197349 Pyrrolo[2,3-D]pyrimidine compounds |
| 09/08/2005 | US20050197343 N-[(4-phenyl-1-piperazinyl)alkyl]-substituted heteroarene carboxamide or 2-ferrocenyl compounds; psychiatric diseases: schizophrenia , unipolar depression, disturbances of consciousness, antidepressant; neurodegenerative diseases: Parkinson's disease, attention deficit hyperactivity syndrome; drug abuse |
| 09/08/2005 | US20050197331 Novel anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production |
| 09/08/2005 | US20050197329 drugs such as 4-(4-{[amino(2-thienyl)methylidene]amino}phenyl)-N-(4-phenoxyphenyl)butanamide, used as nitric oxide synthase inhibitors and selective or non-selective traps for reactive oxygen species |
| 09/08/2005 | US20050197328 2-(4-amino-furazan-3-yl)-1-ethyl-N-[(2R)-2-morpholinylmethyl]-1H-imidazo[4,5-c]pyridine-7-carboxamide; Mitogen- and Stress-Activated Protein (MSK) and Rho (guanosine triphosphate) 1 or 2 kinase inhibitor; neurodegenerative diaeases; antiinflammatory, anticarcinogenic, antiviral and antibacterial agent |
| 09/08/2005 | US20050197320 Phosphonate and sulfide substituted imidazole compounds; antihuman immunodeficiency viral agents |
| 09/08/2005 | US20050197300 Microdose therapy |
| 09/08/2005 | US20050197299 Peptidomimetic protease inhibitors |
| 09/08/2005 | US20050197286 Method for control of depression using c terminal growth hormone (gh) fragment |
| 09/08/2005 | US20050197284 Providing acute neuroprotection by contacting neuronal cells with erythropoietin or active fragment or analog thereof close to or subsequent to time of excitatory insult and contacting cells with insulin-like growth factor, thereby producing synergistic acute neuroprotective effect; Alzheimer's disease |
| 09/08/2005 | US20050196838 Reduced immunogenicity; increased affinity and avidity; improved cell culturing |
| 09/08/2005 | US20050196813 Heterocyclic sulfonamide inhibitors of beta amyloid production |
| 09/08/2005 | US20050196797 PI-3-kinase-related kinase polypeptide for use as tool in identifying modulators for prevntion and treatment of cell proliferation disorders |
| 09/08/2005 | US20050196783 Nucleotide sequences coding r-ounidabout (robo) regulatory protein (SLIT polypeptides) for use in treatment and prevention of nervous system disorders; nerve cell function modulators |
| 09/08/2005 | US20050196751 Receptor protein is capable of activating transcription of desired gene when in presence of agonist and when bound to antagonist; gene therapy; gene expression inhibition; transgenic cells, animals |
| 09/08/2005 | US20050196474 Supplement foods and pharmaceuticals |
| 09/08/2005 | US20050196471 Processes of making north american ginseng fractions, products containing them, and use as immunomodulators |
| 09/08/2005 | US20050196443 Pulsatile release compositions and methods for enhanced intestinal drug absorption |
| 09/08/2005 | US20050196378 G-CSF conjugates |
| 09/08/2005 | US20050196346 Micronized or spray dried solid active ingredient (oxitropium or tiotropium salts which are soluble in water), and coating consisting of fatty acid, alcohol derivative, and poloxamer |